Goldenwell Biotech (GWLL) Other Working Capital Changes (2021 - 2024)

Goldenwell Biotech has reported Other Working Capital Changes for 4 years, with the latest figure at -$54.0 in Q4 2024.

• For the quarter ending Q4 2024, Other Working Capital Changes changed N/A year-over-year to -$54.0; the trailing twelve-month figure through Sep 2025 stood at -$54.0 (changed 0.0% YoY), and the FY2024 full-year result was -$54.0, up 99.79% from the prior year.
• Other Working Capital Changes for Q4 2024 stood at -$54.0, roughly flat from -$54.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $62586.0 in Q1 2021, with the low at -$25372.0 in Q1 2023.
• Historically, Other Working Capital Changes has averaged $3554.2 across 4 years, with a median of -$3747.0 in 2022.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 578.4% — and 2024, when it surged 99.79%.
• Goldenwell Biotech's Other Working Capital Changes stood at -$3690.0 in 2021, then dropped by 1.73% to -$3754.0 in 2022, then tumbled by 575.87% to -$25372.0 in 2023, then surged by 99.79% to -$54.0 in 2024.
• The last three Other Working Capital Changes figures came in at -$54.0 (Q4 2024), -$54.0 (Q1 2024), and -$25372.0 (Q3 2023), per Business Quant data.